NIBIB's Grace Peng provides an overview of the new NIH Bridge2AI program in an interview with Mimi Geerges. Source: Government Matters
NIBIB in the News · September 19, 2022
New computed tomography (CT) technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional CT, according to a new study. Source: Science Daily/Radiological Society of North America
NIBIB in the News · September 19, 2022
NIBIB Intramural Research Program labs collaborate with other NIH researchers on tackle engineering challenges.
Press Releases · September 15, 2022
A research team funded by the National Institutes of Health has shown that commercially available rapid antigen tests can detect past and present variants of concern and has identified potential mutations that may impact test performance in the future.
NIBIB in the News · September 15, 2022
The use of rapid Covid tests has soared this year with the spread of omicron and free shipments organized by the Biden Administration. But in August the US Food and Drug Administration cautioned that people who get a negative result should still repeat the test a couple days later. That communication has led to a lot of confusion. Source: Bloomberg
NIBIB in the News · September 9, 2022
NIH announced it will provide funding to diagnostic test manufacturers for the development of the next generation of COVID-19 tests, with a focus on improved accessibility. Source: LabPulse
Press Releases · September 8, 2022
NIH has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 diagnostics.
Press Releases · August 26, 2022
The NIH announced the winners of the DEBUT Challenge with prizes totaling $130,000
Press Releases · August 26, 2022
A new study that could have immediate implications for COVID-19 testing in schools found that with age-appropriate instructions, school-aged children can successfully use a nasal swab to obtain their own COVID-19 test specimen.